University of California Irvine-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of California Irvine - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013484
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of California Irvine (UCI), a subsidiary of University of California is an educational university that provides undergraduate and graduate degree courses and research services. The university provides educational courses in various fields such as business, education, engineering, arts, biological sciences, and school of medicine, social ecology, program in nursing science, interdisciplinary studies, law, medicine, public health, humanities, information and computer sciences; social sciences, pharmaceutical sciences, and physical sciences, among others. The university also supports, promotes and facilitates various research activities. It operates various research activities with the help of research institutions. The university also provides training and education on research activities. UCI is headquartered in Irvine, California, the US.

University of California Irvine – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of California Irvine, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of California Irvine, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of California Irvine, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of California Irvine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of California Irvine, Medical Devices Deals, 2011 to YTD 2017 9
University of California Irvine, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
University of California Irvine, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Novoheart Enters into Research Agreement with University of California Irvine 11
Licensing Agreements 12
Novoheart Enters into Licensing Agreement with University of California Irvine 12
Thesan Pharma Enters into Licensing Agreement with University of California, Irvine 13
ChromaDex Enters Into Licensing Agreement With University Of California, Irvine 14
Repligen Enters Into Licensing Agreement With UCI 15
University of California Irvine – Key Competitors 16
University of California Irvine – Key Employees 17
University of California Irvine – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 20
Government and Public Interest 20
Sep 18, 2017: UCI receives $200 million gift to name College of Health Sciences and launch major integrative health initiative 20
Jul 26, 2017: UCI Stem Cell Therapy Attacks Cancer by Targeting Unique Tissue Stiffness 22
Aug 01, 2016: UCI scientists identify a new approach for treating skin cancer 23
Mar 28, 2016: UCI scientists receive $8 million to help develop Q fever vaccine 24
Feb 29, 2016: Genetic Link to Parkinson’s Disease Is Best Hope for the Future in Rare Disease 25
Product News 26
Jul 05, 2016: Unique Alzheimer’s Disease Vaccines Show Great Potential in Pre-Clinical Studies 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
University of California Irvine, Pharmaceuticals & Healthcare, Key Facts 2
University of California Irvine, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of California Irvine, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of California Irvine, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of California Irvine, Deals By Therapy Area, 2011 to YTD 2017 8
University of California Irvine, Medical Devices Deals, 2011 to YTD 2017 9
University of California Irvine, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Novoheart Enters into Research Agreement with University of California Irvine 11
Novoheart Enters into Licensing Agreement with University of California Irvine 12
Thesan Pharma Enters into Licensing Agreement with University of California, Irvine 13
ChromaDex Enters Into Licensing Agreement With University Of California, Irvine 14
Repligen Enters Into Licensing Agreement With UCI 15
University of California Irvine, Key Competitors 16
University of California Irvine, Key Employees 17
University of California Irvine, Subsidiaries 18

★海外企業調査レポート[University of California Irvine-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tocagen Inc (TOCA):製薬・医療:M&Aディール及び事業提携情報
    Summary Tocagen Inc (Tocagen) is a clinical-stage cancer-selective gene therapy company that develops and commercializes product candidates for the treatment of cancer. The company offers lead product candidate such as Toca 511 and Toca FC, which is being investigated for the treatment of recurrent …
  • DTE Energy Co (DTE):企業の財務・戦略的SWOT分析
    DTE Energy Co (DTE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • HCL Technologies Limited:企業の戦略・SWOT・財務分析
    HCL Technologies Limited - Strategy, SWOT and Corporate Finance Report Summary HCL Technologies Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • RH Petrogas Ltd (T13):石油・ガス:M&Aディール及び事業提携情報
    Summary RH Petrogas Ltd (RH Petrogas) is an oil and gas company that explores, develops and produces oil and gas resources. The company’s properties include FUYU 1 block, Basin and Island PSC, and SK331 PSC. Its FUYU 1 block property is located in south-east of the Fuyu oilfield in the Jilin provinc …
  • Marvell Technology Group Ltd.:企業の戦略・SWOT・財務分析
    Marvell Technology Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Marvell Technology Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • A.H.A International Co., Ltd.:戦略・SWOT・企業財務分析
    A.H.A International Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary A.H.A International Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • PricewaterhouseCoopers LLP (UK):企業の戦略的SWOT分析
    PricewaterhouseCoopers LLP (UK) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • SAES Getters S.p.A. (SG):企業の財務・戦略的SWOT分析
    SAES Getters S.p.A. (SG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • United International Enterprises Limited:企業の戦略・SWOT・財務情報
    United International Enterprises Limited - Strategy, SWOT and Corporate Finance Report Summary United International Enterprises Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Delphi Automotive Plc (APTV):企業の財務・戦略的SWOT分析
    Delphi Automotive Plc (APTV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • PCCW Limited:戦略・SWOT・企業財務分析
    PCCW Limited - Strategy, SWOT and Corporate Finance Report Summary PCCW Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Red Electrica Corporacion, S.A.:企業の戦略・SWOT・財務情報
    Red Electrica Corporacion, S.A. - Strategy, SWOT and Corporate Finance Report Summary Red Electrica Corporacion, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Immuno-Biological Laboratories Co Ltd (4570):製薬・医療:M&Aディール及び事業提携情報
    Summary Immuno-Biological Laboratories Co Ltd (IBL) is a pharmaceutical company that develops, manufactures and markets diagnostic products. The company provides business areas such as diagnostic and research reagents, customized services, global sales network, protein production business using tran …
  • Sojitz Corporation (2768):企業の財務・戦略的SWOT分析
    Sojitz Corporation (2768) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Wingstop Inc.:企業の戦略・SWOT・財務情報
    Wingstop Inc. - Strategy, SWOT and Corporate Finance Report Summary Wingstop Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Hutchinson SA:企業の戦略的SWOT分析
    Hutchinson SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Clover Corp Ltd (CLV):企業の財務・戦略的SWOT分析
    Summary Clover Corporation Limited (Clover), is a developer of science-based bioactives. The company offers products such as DHA oils, DHA powders and microencapsulation. It delivers bioactive ingredients through encapsulation. Clover’s refined tuna oil is used in various formulations, supplements, …
  • Rostelecom:企業の戦略・SWOT・財務情報
    Rostelecom - Strategy, SWOT and Corporate Finance Report Summary Rostelecom - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Allscripts Healthcare Solutions Inc (MDRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Allscripts Healthcare Solutions Inc (Allscripts), formerly Allscripts-Misys Healthcare Solutions, Inc., is a provider of healthcare information technology solutions. The company’s major solutions include Electronic Health Records (EHR), Financial Management Solutions, Population Health Manag …
  • GMR Infrastructure Ltd (GMRINFRA):企業の財務・戦略的SWOT分析
    GMR Infrastructure Ltd (GMRINFRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆